TytoCare Ltd., a company developing state-of-the-art handheld devices and telehealth platform enabling patients to perform home medical examinations and consult with a remote clinician, is closing an $11 million Series B round led by Cambia Health Solutions. TytoCare is also backed by major investors including OrbiMed Advisors, Walgreens, Fosun Pharma and LionBird.
Learn more about TytoCare and its groundbreaking telehealth technology by visitng mHealthNews.
